Llwytho...
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
BACKGROUND: In 2016, the World Health Organization reclassified the definition of glioblastoma (GBM), dividing these tumors into isocitrate dehydrogenase (IDH)-wild-type and IDH-mutant GBM, where the vast majority of GBMs are IDH-wild-type. Nomograms are useful tools for individualized estimation of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neurooncol Adv |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6777501/ https://ncbi.nlm.nih.gov/pubmed/31608326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz007 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|